Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CEO Amit Gupta sold 15,160 shares of the stock in a transaction that occurred on Friday, January 24th. The stock was sold at an average price of $3.92, for a total value of $59,427.20. Following the completion of the sale, the chief executive officer now owns 215,494 shares in the company, valued at approximately $844,736.48. The trade was a 6.57 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.
Amit Gupta also recently made the following trade(s):
- On Friday, January 3rd, Amit Gupta sold 5,964 shares of Cardlytics stock. The shares were sold at an average price of $3.67, for a total value of $21,887.88.
Cardlytics Stock Up 1.3 %
Shares of Cardlytics stock opened at $3.88 on Friday. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.18. The stock has a market cap of $197.19 million, a price-to-earnings ratio of -0.64 and a beta of 1.53. The firm’s 50-day moving average is $3.66 and its two-hundred day moving average is $4.36. Cardlytics, Inc. has a 1 year low of $2.76 and a 1 year high of $20.52.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently made changes to their positions in CDLX. Tallon Kerry Patrick bought a new position in Cardlytics in the fourth quarter worth about $37,000. Atom Investors LP purchased a new position in shares of Cardlytics in the 3rd quarter worth approximately $33,000. XTX Topco Ltd bought a new position in shares of Cardlytics during the 2nd quarter worth approximately $107,000. SG Americas Securities LLC purchased a new stake in Cardlytics during the third quarter valued at approximately $45,000. Finally, Intech Investment Management LLC acquired a new stake in Cardlytics in the third quarter valued at approximately $47,000. 68.10% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on CDLX shares. Craig Hallum raised shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, November 6th. Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a research report on Friday, January 17th. Finally, Evercore ISI assumed coverage on shares of Cardlytics in a research report on Friday, October 11th. They set an “in-line” rating and a $4.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Cardlytics currently has an average rating of “Hold” and a consensus price target of $6.92.
Read Our Latest Stock Analysis on Cardlytics
Cardlytics Company Profile
Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
Featured Articles
- Five stocks we like better than Cardlytics
- What Investors Need to Know to Beat the Market
- Bloom Energy: Powering the Future With Decentralized Energy
- Investing in the High PE Growth Stocks
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- How to Use the MarketBeat Excel Dividend Calculator
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.